478 related articles for article (PubMed ID: 12187094)
21. Methylenetetrahydrofolate reductase gene C677T polymorphism, plasma homocysteine and folate in end-stage renal disease dialysis and non-dialysis patients.
Zychma MJ; Gumprecht J; Grzeszczak W; Zukowska-Szczechowska E;
Nephron; 2002 Sep; 92(1):235-9. PubMed ID: 12187113
[TBL] [Abstract][Full Text] [Related]
22. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion.
Weger M; Stanger O; Deutschmann H; Leitner FJ; Renner W; Schmut O; Semmelrock J; Haas A
Am J Ophthalmol; 2002 Jul; 134(1):57-61. PubMed ID: 12095808
[TBL] [Abstract][Full Text] [Related]
23. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk.
Lievers KJ; Boers GH; Verhoef P; den Heijer M; Kluijtmans LA; van der Put NM; Trijbels FJ; Blom HJ
J Mol Med (Berl); 2001 Sep; 79(9):522-8. PubMed ID: 11692165
[TBL] [Abstract][Full Text] [Related]
24. The C677T thermolabile variant of methylene tetrahydrofolate reductase on homocysteine, folate and vitamin B12 in a hemodialysis center.
Trimarchi H; Genoud V; Schiel A; Castañon M; Freixas E; Diaz ML; Schropp J; Martino D; Pereyra H; Kordich L
Medicina (B Aires); 2002; 62(2):149-53. PubMed ID: 12038037
[TBL] [Abstract][Full Text] [Related]
25. The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients.
Shpichinetsky V; Raz I; Friedlander Y; Goldschmidt N; Wexler ID; Ben-Yehuda A; Friedman G
J Nutr; 2000 Oct; 130(10):2493-7. PubMed ID: 11015479
[TBL] [Abstract][Full Text] [Related]
26. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
[TBL] [Abstract][Full Text] [Related]
27. Hyperhomocysteinemia and polymorphisms of the methylenetetrahydrofolate gene in hemodialysis and peritoneal dialysis patients.
Domenici FA; Vannucchi MT; Simões-Ambrósio LM; Vannucchi H
Mol Nutr Food Res; 2007 Nov; 51(11):1430-6. PubMed ID: 17966140
[TBL] [Abstract][Full Text] [Related]
28. The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients.
Fukasawa M; Matsushita K; Kamiyama M; Mikami Y; Araki I; Yamagata Z; Takeda M
Am J Kidney Dis; 2003 Mar; 41(3):637-42. PubMed ID: 12612987
[TBL] [Abstract][Full Text] [Related]
29. The C677T methylenetetrahydrofolate reductase gene mutation in hemodialysis patients.
Kimura H; Gejyo F; Suzuki S; Miyazaki R
J Am Soc Nephrol; 2000 May; 11(5):885-893. PubMed ID: 10770966
[TBL] [Abstract][Full Text] [Related]
30. Case-control Study of methylenetetrahydrofolate reductase mutations and hyperhomocysteinemia and risk of stroke.
Almawi WY; Khan A; Al-Othman SS; Bakhiet M
J Stroke Cerebrovasc Dis; 2009; 18(5):407-8. PubMed ID: 19717029
[TBL] [Abstract][Full Text] [Related]
31. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
[TBL] [Abstract][Full Text] [Related]
32. [Methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in hemodialysing patients].
Yao Y; Liu H; Zhang X; Duan X
Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):522-5. PubMed ID: 12421498
[TBL] [Abstract][Full Text] [Related]
33. Plasma homocysteine levels, methylene tetrahydrofolate reductase A1298C gene polymorphism and risk of retinal vein thrombosis.
Ghaznavi H; Soheili Z; Samiei S; Soltanpour MS
Blood Coagul Fibrinolysis; 2016 Sep; 27(6):679-83. PubMed ID: 26650461
[TBL] [Abstract][Full Text] [Related]
34. [Some aspects of homocysteine metabolism in hemodialysis patients].
Bednarek-Skublewska A; Buraczyńska M; Wawrzycki S; Baranowicz-Gaszczyk I; Ksiazek A
Pol Arch Med Wewn; 2002 Nov; 108(5):1041-7. PubMed ID: 12685244
[TBL] [Abstract][Full Text] [Related]
35. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations.
Isotalo PA; Wells GA; Donnelly JG
Am J Hum Genet; 2000 Oct; 67(4):986-90. PubMed ID: 10958762
[TBL] [Abstract][Full Text] [Related]
36. The C677T mutation in the methylenetetrahydrofolate reductase gene contributes to hyperhomocysteinemia in patients taking anticonvulsants.
Ono H; Sakamoto A; Mizoguchi N; Sakura N
Brain Dev; 2002 Jun; 24(4):223-6. PubMed ID: 12015164
[TBL] [Abstract][Full Text] [Related]
37. Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.
Födinger M; Buchmayer H; Heinz G; Papagiannopoulos M; Kletzmayr J; Perschl A; Vychytil A; Hörl WH; Sunder-Plassmann G
Am J Kidney Dis; 2001 Jul; 38(1):77-84. PubMed ID: 11431185
[TBL] [Abstract][Full Text] [Related]
38. A C677T mutation in the methylenetetrahydrofolate reductase gene modifies serum cysteine in dialysis patients.
Kimura H; Gejyo F; Suzuki S; Takeda T; Miyazaki R; Yoshida H
Am J Kidney Dis; 2000 Nov; 36(5):925-33. PubMed ID: 11054348
[TBL] [Abstract][Full Text] [Related]
39. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
[TBL] [Abstract][Full Text] [Related]
40. The effect of methylenetetrahydrofolate reductase C677T common variant on hypertensive risk is not solely explained by increased plasma homocysteine values.
Rodríguez-Esparragón F; Hernández-Perera O; Rodríguez-Pérez JC; Anábitarte A; Díaz-Cremades JM; Losada A; Fiuza D; Hernández E; Yunis C; Ferrario CM
Clin Exp Hypertens; 2003 May; 25(4):209-20. PubMed ID: 12797595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
